QUOTE
Rosetta Genomics Ltd (ROSG)
$
0.43
 -0.12 (-21.82%) Jan 26
|
10 Plaut Street Science Park POB 4059,
Rehovot, 76706,
ISR
+972-8-9484755
http://www.rosettagenomics.com/ |
|
|
| PRICES |
| Open |
Volume |
| 0.60 |
4.09M |
| High |
Low |
| 0.75 |
0.42 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 7 |
103,500 |
| 52wk High |
52wk Low |
| 1.80 |
0.18 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 0.04 |
10.75 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| 16.90 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2004 | 2005 | 2006 | 2007 | 2008 | 2009 |
| Income statement |
| Total Revenue |
- | - | - | - | - | $0.15 |
| Operating Income |
$-2.98 | $-5.18 | $-8.14 | $-11.04 | $-14.70 | $-14.80 |
| Net Income |
$-2.98 | $-5.84 | $-7.61 | $-14.66 | $-9.46 | $-16.50 |
| Balance Sheet |
| Total Assets |
$2.08 | $5.37 | $13.24 | $26.04 | $20.27 | $12.74 |
| Total Equity |
$1.29 | $-2.32 | $11.10 | $23.61 | $16.10 | $6.84 |
| Total Liabilities |
$0.79 | $7.69 | $2.14 | $2.43 | $4.17 | $5.90 |
| Cash Flow |
| Operating |
$-1.15 | $-4.16 | $-6.41 | - | $-11.94 | $-11.77 |
| Investing |
$-0.14 | $-0.15 | $-5.60 | - | $11.35 | $-5.16 |
| Financing |
$1.76 | $7.72 | $12.32 | - | $0.80 | $6.45 |
| Net Cash Change |
$0.46 | $3.40 | $0.31 | - | $0.22 | $-10.48 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
31 March 2010
26 May 2010
07 Septempber 2010
30 November 2010
|
26 March 2009
21 May 2009
08 Septempber 2009
18 December 2009
|
19 August 2008
05 December 2008
|
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
| 10K Reports |
Annual Reports |
| |
| Ticker News
|
|
| |
Management
|
|
Executive |
Title |
|
Yoav Z. Chelouche |
Chairman of the Board | |
|
Amir Avniel |
President, Chief Executive Officer |
|
Tamir Kazaz |
Chief Financial Officer |
|
Isaac Bentwich |
Chief Architect, Director |
|
Ranit Aharonov |
Executive Vice President - IP and Computational Biology |
|
Dalia Cohen |
Executive Vice President, Global Head - Research and Development |
|
Ayelet Chajut |
Vice President - Diagnostics |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
